Patents by Inventor Mohammad Michel AFSHAR

Mohammad Michel AFSHAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT
    Publication number: 20220226278
    Abstract: The present disclosure provides genetic polymorphisms associated with an altered response of a subject to Sigma-1 receptor therapy. Also described is use of the polymorphisms to personalize treatment for subjects in need of Sigma-1 receptor therapy such as treatment of neurodevelopmental and neurodegenerative diseases and conditions.
    Type: Application
    Filed: May 20, 2019
    Publication date: July 21, 2022
    Applicant: ANAVEX LIFE SCIENCES CORP.
    Inventors: Christopher U. MISSLING, Mohammad Michel AFSHAR, Frédéric PARMENTIER